Metraipolis › archive › dc_2d44db0a41b5
Targeting NXPH4/ALDH1L2 signaling suppresses enzalutamide resistance in prostate cancer — Europe PMC PMID:41639054
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41639054
- DOI
- 10.1038/s41420-[numero omesso]-z
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T03:07:59.159Z
- SHA-256 of the archived text
6bf6c85d6b8a2ec3f6bd21893444100ec28e24dd07de12e78ee62c4572c9ef07- Stable URL of this page
https://metraipolis.com/documento/dc_2d44db0a41b5
How to cite
Targeting NXPH4/ALDH1L2 signaling suppresses enzalutamide resistance in prostate cancer — Europe PMC PMID:41639054 — Europe PMC (en), https://europepmc.org/article/MED/41639054 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2d44db0a41b5 (Metraipolis archive dc_2d44db0a41b5, sha256 6bf6c85d6b8a2ec3f6bd21893444100ec28e24dd07de12e78ee62c4572c9ef07)
BibTeX
@misc{dc2d44db0a41b5,
title = {Targeting NXPH4/ALDH1L2 signaling suppresses enzalutamide resistance in prostate cancer — Europe PMC PMID:41639054},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41639054},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2d44db0a41b5; sha256 6bf6c85d6b8a2ec3f6bd21893444100ec28e24dd07de12e78ee62c4572c9ef07},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41639054. Agents can read the archived copy with the MCP tool read_document.